14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.53 $28.69 Friday, 3rd May 2024 INSM stock ended at $25.55. This is 0.429% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $25.40 to a day high of $26.43.
90 days $23.53 $29.91
52 weeks $18.09 $32.00

Historical Insmed prices

Date Open High Low Close Volume
Jun 12, 2023 $19.94 $20.09 $19.29 $19.50 777 524
Jun 09, 2023 $20.11 $20.11 $19.64 $19.80 513 848
Jun 08, 2023 $19.72 $20.10 $19.47 $20.03 709 375
Jun 07, 2023 $19.46 $19.92 $19.21 $19.78 818 930
Jun 06, 2023 $19.43 $19.80 $19.23 $19.46 608 223
Jun 05, 2023 $19.37 $19.79 $19.26 $19.47 1 030 843
Jun 02, 2023 $19.49 $19.74 $19.23 $19.54 680 149
Jun 01, 2023 $19.19 $19.69 $18.80 $19.24 1 026 087
May 31, 2023 $18.77 $19.17 $18.69 $19.03 707 986
May 30, 2023 $18.79 $18.96 $18.31 $18.69 898 051
May 26, 2023 $18.84 $19.01 $18.59 $18.79 559 706
May 25, 2023 $19.18 $19.25 $18.69 $18.70 912 549
May 24, 2023 $18.99 $19.36 $18.68 $19.29 930 793
May 23, 2023 $20.38 $20.51 $19.12 $19.16 741 080
May 22, 2023 $19.54 $20.36 $19.53 $20.31 2 113 680
May 19, 2023 $19.05 $19.50 $18.72 $19.46 818 351
May 18, 2023 $18.73 $19.24 $18.34 $18.82 1 178 327
May 17, 2023 $18.48 $18.62 $18.09 $18.56 955 343
May 16, 2023 $18.85 $18.92 $18.21 $18.38 847 438
May 15, 2023 $18.84 $19.42 $18.84 $19.27 615 593
May 12, 2023 $18.95 $19.21 $18.52 $18.73 551 885
May 11, 2023 $19.02 $19.08 $18.68 $18.95 646 351
May 10, 2023 $19.19 $19.45 $18.83 $19.17 770 101
May 09, 2023 $18.76 $19.20 $18.58 $18.93 918 478
May 08, 2023 $19.56 $19.59 $18.76 $18.90 829 499
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT